News

Hansa Biopharma AB has appointed Maria Törnsén as Chief Operating Officer (COO) and President U.S., effective May 19.
Xmoor Pharma has entered into a strategic partnership with KU Leuven to support a new cell and gene therapy hub.
Recipharm and ProductLife Group (PLG) have joined forces to support (bio)pharmaceutical companies in accelerating time to ...
Bora Pharmaceuticals Co., Ltd., a pharmaceutical manufacturer, has appointed Jean-Baptiste (JB) Agnus as Chief Commercial ...
Stylus Medicine Inc., a biotechnology company dedicated to developing transformative in vivo genetic medicines, has emerged ...
Rockwell Automation, a company dedicated to industrial automation and digital transformation, has launched FactoryTalk ...
Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX Pro HT NoSpin Plasmid MiniPrep Kit to address the critical need for rapid and automated plasmid DNA isolation, enabling scientists ...
Genentech has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility.
Piramal Pharma Limited has committed to a $90 million investment plan towards expanding two of its U.S. facilities.
Advanced analytics leverages machine learning (ML), statistical modeling, data mining and visualizations to empower ...
Ratio has entered into an agreement with Wasatch Group to partner and construct a radiopharmaceutical research and ...
Dr. Conrad brings over 30 years of experience spanning R&D, strategy and operations, business and corporate development, ...